A factory may finish production on schedule while its goods remain unavailable for dispatch. Sampling, laboratory work and authorised release create another queue after the processing line. The operating model should make that queue visible, with enough storage and working capital to support it. Laboratory capacity is therefore part of the factory's delivery promise rather than a detached quality expense.
Define what permits release
Qualified food-safety teams should establish the controls and evidence required for each product and process. FAO's GHP and HACCP resources provide the broader preventive framework. The management system should identify which checks occur during production and which results must be available before a batch can move to the next status. Finished goods awaiting a decision should remain distinct from stock available for sale. A production completion timestamp alone cannot establish that the customer order is ready to leave under the agreed quality arrangements.
Release forecasts should also be visible to the team booking vehicles. A dispatch slot reserved before the batch is realistically available can create waiting charges or missed collections, turning a laboratory timing issue into an avoidable logistics expense.
Map the analytical timetable
A hypothetical plant may send samples to an external laboratory only at the end of the day, missing its routine receiving window. The physical test may be efficient while transport and accessioning create most of the wait. The contract should describe sample acceptance, reporting and communication, with requirements set by qualified personnel. The factory should compare the complete elapsed time with its dispatch plan. The analysis needs to distinguish unavoidable technical duration from delays caused by collection schedules or incomplete paperwork that the parties can improve.
Price the stock held for a decision
The working-capital model should include the material, packaging and other cash committed while goods remain on hold. Storage requirements and the consequences of an unexpected result also belong in the plan. A shorter assumed release interval can make a project appear less capital-intensive without changing the actual service. Managers should know how additional held batches would be accommodated and who can change production or dispatch commitments. The cost of testing should therefore be evaluated alongside the inventory and flexibility associated with the chosen arrangement.
Track release performance and exceptions
The report should show production completion, sample dispatch, result availability and authorised release as separate stages. Recurring delays can then be assigned to the appropriate owner. A testing invoice is one input to service evaluation, with accepted reports and usable timing carrying equal commercial significance. The factory should preserve quality authority when customers request urgent shipment. A dependable release process gives sales a realistic availability date and management a clearer investment choice between laboratory arrangements, logistics and storage, grounded in the specific stage that holds up saleable inventory.
